Ekana Pharmaceuticals (Opc) Private Limited - Company Profile

It is a trading enterprise based in Lucknow, Uttar Pradesh, India, established in 2019.
2019 Lucknow, Uttar Pradesh, India Active
Last Updated:
About Ekana Pharmaceuticals (Opc) Private Limited

Ekana Pharmaceuticals (Opc) Private Limited, Engaging in specialty within the trading sector, it holds CIN: U51909UP2019OPC122966. Registered under ROC Roc Uttar Pradesh I. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Shweta Misra (Managing Director). Past directors included Dhananjay Kumar Mishra. Its latest balance sheet filed on 31 March 2023. It is based at Plot No. 29,Gata No. 215 Vill Barkhurdarpur, Mohana, Lucknow, Uttar Pradesh, 226021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909UP2019OPC122966

  • Registration Number

    122966

  • Incorporation Date

    04 November 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Uttar Pradesh I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 4 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth **** %
  • Profit Growth **** -9.04%
  • Ebitda **** -9.04%
  • Net Worth -14.96%
  • Total Assets -13.28%
Company report

Ekana Pharmaceuticals (Opc) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ekana Pharmaceuticals (Opc) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ekana Pharmaceuticals (Opc) Private Limited?
Current Directors
Name Designation Appointment Date Status
Shweta Misra Managing Director 04 Nov 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Nominee - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ekana Pharmaceuticals (Opc).

Ekana Pharmaceuticals (Opc) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 9.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.96%.

Ekana Pharmaceuticals (Opc) revenue growth over time
Ekana Pharmaceuticals (Opc) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
-13.28%
*******
*******
*******
*******
Profit or Loss
*******
-9.04%
*******
*******
*******
*******
Net Worth
*******
-14.96%
*******
*******
*******
*******
EBITDA
*******
-9.04%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ekana Pharmaceuticals (Opc)?

Unlock access to Ekana Pharmaceuticals (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ekana Pharmaceuticals (Opc)?

Unlock and access historical data on people associated with Ekana Pharmaceuticals (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ekana Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ekana Pharmaceuticals (Opc)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ekana Pharmaceuticals (Opc)
Recent Activity within the Organization
  • Balance Sheet

    Ekana Pharmaceuticals (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Uttar Pradesh I. was recorded as a recent event.

  • Director Appointment

    The activity Shweta Misra was appointed as a Managing Director was appointed as a Managing Director on 04 Nov 2019 & has been associated with this company since 6 years 4 months . was completed.

  • Company Incorporation

    The activity Ekana Pharmaceuticals (Opc) Private Limited was registered on 04 Nov 2019 with Roc Uttar Pradesh I & aged 6 years 4 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ekana Pharmaceuticals (Opc) Private Limited?

The CIN of Ekana Pharmaceuticals (Opc) Private Limited is U51909UP2019OPC122966.

Where is Ekana Pharmaceuticals (Opc) Private Limited headquartered?

Ekana Pharmaceuticals (Opc) Private Limited is headquartered at Plot No. 29,Gata No. 215 Vill Barkhurdarpur, Mohana, Lucknow, Uttar Pradesh, 226021.

When was Ekana Pharmaceuticals (Opc) Private Limited incorporated?

Ekana Pharmaceuticals (Opc) Private Limited was incorporated on 04 November 2019.

Who are the current directors of Ekana Pharmaceuticals (Opc) Private Limited?

The current directors of Ekana Pharmaceuticals (Opc) Private Limited are

What is the primary industry of Ekana Pharmaceuticals (Opc) Private Limited?

The primary industry of Ekana Pharmaceuticals (Opc) Private Limited is Trading.

Is Ekana Pharmaceuticals (Opc) Private Limited a listed company?

Ekana Pharmaceuticals (Opc) Private Limited is unlisted.

What is the capital structure of Ekana Pharmaceuticals (Opc) Private Limited?

The authorized capital of Ekana Pharmaceuticals (Opc) Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available